A Weekend of Their Own
Many patients will tell you that battling cancer is a full-time job with little to no “down time.” This is especially true for patients with MBC, who must cope daily with grueling treatment schedules
Many patients will tell you that battling cancer is a full-time job with little to no “down time.” This is especially true for patients with MBC, who must cope daily with grueling treatment schedules
Welcome! You are invited to join a webinar: Improving Care in Early-Stage NSCLC: Optimizing Biomarker Testing, Treatment Planning, and Care Coordination. After registering, you will…
The 2025 ACCC Innovator Awards will recognize and support ACCC Cancer Program Members that have developed forward-thinking strategies to meet the new reality of cancer…
For more insight into their upcoming session at the 51st AMCCBS, “The Importance of Pairing Women’s Health and Oncology,” ACCCBuzz recently spoke with Tessa Kerby…
As treatment paradigms for CLL continue to evolve with new research and emerging therapies, health care providers must stay current through continuous education.
The 2025 ACCC Innovator Awards will recognize and support ACCC Cancer Program Members that have developed forward-thinking strategies to meet the new reality of cancer…
You must have an ACCC account in order to register for this webinar. To start, click the green “Register” button in the upper right corner…
Read the newest installment from Barbara Schmidtman, PhD, vice president of cancer care operations, Corewell Health, in her leadership blog series, as she details the…
Review the insights shared at the 2024 NCCN Patient Advocacy Summit about efforts to combat misinformation and advance health literacy in the evolving landscape of…
Editor-in-Chief: Krista Nelson, LCSW, OSW-C, FAOSW, FAPOS, FACCC Oncology Issues, Article, Volume 39, Over the last 2 decades, the development of bispecific antibodies (BsAbs) has…
Editor-in-Chief: Krista Nelson, LCSW, OSW-C, FAOSW, FAPOS, FACCC Oncology Issues, Article, Volume 39, Colorectal cancer ranks as the third most common cancer globally and is…